India Pharmaceutical Manufacturing Market Size, Share 2033

India Pharmaceutical Manufacturing Market Size, Share, Trends and Forecast by Molecule Type, Drug Development Type, Formulation, Route of Administration, Therapy Area, Prescription, Age Group, Sales Channel, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A33217

Buy Now Discount
Offer

India Pharmaceutical Manufacturing Market Overview:

The India pharmaceutical manufacturing market size reached USD 19.25 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.13 Billion by 2033, exhibiting a growth rate (CAGR) of 6.91% during 2025-2033. India's pharmaceutical manufacturing market is driven by a combination of cost-effective production capabilities, strong domestic demand, robust export opportunities for generics and biosimilars, supportive government policies like the PLI scheme, elevating demand for affordable healthcare solutions, and a well-established medical infrastructure network backed by a large pool of skilled professionals and R&D expertise.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 19.25 Billion
Market Forecast in 2033	USD 35.13 Billion
Market Growth Rate 2025-2033	6.91%

India Pharmaceutical Manufacturing Market Trends:

Cost-Effective Manufacturing and Skilled Workforce

India's pharmaceutical manufacturing industry is driven mainly by its affordable production capacity and large pool of skilled manpower. The country provides considerable cost benefits over Western counterparts, especially in the manufacturing of generic medicines, Active Pharmaceutical Ingredients (APIs), and bulk drugs. Indian producers enjoy lower labor costs, affordable infrastructure, and competitive utility charges, making it one of the most cost-effective pharma hubs in the world. This cost benefit enables Indian pharmaceutical companies to provide competitive pricing in the local as well as export markets. International pharmaceutical leaders tend to outsource or create manufacturing facilities in India to decrease their production costs without sacrificing the quality. WHO-GMP-approved facilities and conformity to US FDA and EU laws further enhance the country's international manufacturing attractiveness. Besides, India's vast number of scientifically qualified personnel, such as chemists, pharmacists, biotechnologists, and engineers, provides significantly to the productivity and innovative potential of the sector. A number of premier institutions like the Indian Institutes of Technology (IITs), National Institutes of Pharmaceutical Education and Research (NIPERs), and various medical colleges provide a steady supply of skilled manpower.

India Pharmaceutical Manufacturing Market Size

Rising Global Demand for Generic Drugs and Biosimilars

A key driver for India's pharmaceutical manufacturing business is the escalating global demand for biosimilars and generic pharmaceuticals. As health systems globally face increased treatment expenditures and aging populations, the necessity for cost-effective but effective medicines is accelerating. Generic medicines and affordable substitutes of patented medicines after the expiration of patents are now necessities for the plans of public as well as private health systems. India, labeled the "Pharmacy of the World", is a key player in fulfilling this requirement by providing more than 20% of global generic medicines. Indian pharma firms have made themselves adept at the process of reverse engineering and process improvement, allowing them to manufacture generics in high volumes and with great speed, frequently within months of worldwide patent expirations. Additionally, India has the largest number of US FDA-approved pharma manufacturing plants outside of the United States, further cementing its reliability and trustworthiness as an international generics supplier.

India Pharmaceutical Manufacturing Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on molecule type, drug development type, formulation, route of administration, therapy area, prescription, age group, and sales channel.

Molecule Type Insights:

Biologics and Biosimilars (Large Molecules)
- Monoclonal Antibodies
- Vaccines
- Cell and Gene Therapy
- Others
Conventional Drugs (Small Molecules)

The report has provided a detailed breakup and analysis of the market based on the molecule type. This includes biologics and biosimilars (large molecules) (monoclonal antibodies, vaccines, cell and gene therapy, and others) and conventional drugs (small molecules).

Drug Development Type Insights:

In-House
Outsource

A detailed breakup and analysis of the market based on the drug development type have also been provided in the report. This includes in-house and outsource.

Formulation Insights:

Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Others

The report has provided a detailed breakup and analysis of the market based on the formulation. This includes tablets, capsules, injectable, sprays, suspensions, powders, and others.

Route of Administration Insights:

Oral
Topical
Parenteral
Inhalations
Others

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, topical, parenteral, inhalations, and others.

Therapy Area Insights:

Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Others

A detailed breakup and analysis of the market based on the therapy area have also been provided in the report. This includes cardiovascular diseases (CVDs), pain, diabetes, cancer, respiratory diseases, and others.

Prescription Insights:

Prescription Medicines
Over-the-counter (OTC) Medicines

A detailed breakup and analysis of the market based on the prescription have also been provided in the report. This includes prescription medicines and over-the-counter (OTC) medicines.

Age Group Insights:

Children and Adolescents
Adults
Geriatric

A detailed breakup and analysis of the market based on the age group have also been provided in the report. This includes children and adolescents, adults, and geriatric.

Sales Channel Insights:

Retail
Non-Retail

A detailed breakup and analysis of the market based on the sales channel have also been provided in the report. This includes retail and non-retail.

Regional Insights:

North India
South India
East India
West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Pharmaceutical Manufacturing Market News:

November 2024: ACG Engineering launched the ADAPT X feeder at CPhI & PMEC India 2024, designed to handle complex tablet shapes with high-speed, tool-less changeovers. This innovation enhances packaging flexibility and efficiency in pharmaceutical manufacturing.
November 2024: Clariant introduced eight high-performing excipients at CPHI India 2024, including the VitiPure LEX series and Polyglykol 1450 S, aimed at enhancing drug formulation and delivery. It reportedly combines Swiss expertise with local manufacturing in India to support the pharmaceutical industry's evolving needs.
November 2024: Pfizer announced that it would be expanding its manufacturing and R&D capacities in India by shifting oncology and chemotherapy production from Australia to Gujarat and increasing R&D staff in Chennai. This move would enhance local production, with nearly 70% of Pfizer's Indian sales being manufactured domestically.

India Pharmaceutical Manufacturing Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Molecule Type Drug Development Type Formulation Route of Administration Therapy Area Prescription Age Group Sales Channel Region
Molecule Types Covered	Biologics and Biosimilars (Large Molecules): Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Others Conventional Drugs (Small Molecules)
Drug Development Types Covered	In-House, Outsource
Formulations Covered	Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others
Routes of Administration Covered	Oral, Topical, Parenteral, Inhalations, Others
Therapy Areas Covered	Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Others
Prescriptions Covered	Prescription Medicines, Over-the-counter (OTC) Medicines
Age Groups Covered	Children and Adolescents, Adults, Geriatric
Sales Channels Covered	Retail, Non-Retail
Regions Covered	North India, South India, East India, West India
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India pharmaceutical manufacturing market performed so far and how will it perform in the coming years?
What is the breakup of the India pharmaceutical manufacturing market on the basis of molecule type?
What is the breakup of the India pharmaceutical manufacturing market on the basis of drug development type?
What is the breakup of the India pharmaceutical manufacturing market on the basis of formulation?
What is the breakup of the India pharmaceutical manufacturing market on the basis of route of administration?
What is the breakup of the India pharmaceutical manufacturing market on the basis of therapy area?
What is the breakup of the India pharmaceutical manufacturing market on the basis of prescription?
What is the breakup of the India pharmaceutical manufacturing market on the basis of age group?
What is the breakup of the India pharmaceutical manufacturing market on the basis of sales channel?
What are the various stages in the value chain of the India pharmaceutical manufacturing market?
What are the key driving factors and challenges in the India pharmaceutical manufacturing market?
What is the structure of the India pharmaceutical manufacturing market and who are the key players?
What is the degree of competition in the India pharmaceutical manufacturing market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India pharmaceutical manufacturing market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the India pharmaceutical manufacturing market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India pharmaceutical manufacturing industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.